L'Institut National de Recherche Biomédicale RDC
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Muyembe-Tamfum, Jean-Jacques
NCT04152486: Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Active, not recruiting
3
20426
RoW
Ad26.ZEBOV, MVA-BN-Filo vaccine
London School of Hygiene and Tropical Medicine, Epicentre, Ministère de la Santé de la RDC, Médecins Sans Frontières, France, Coalition for Epidemic Preparedness Innovations, Janssen Vaccines & Prevention B.V., Public Health England
Ebola Virus Disease
01/22
02/22
Bausch, Daniel
NCT04152486: Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Active, not recruiting
3
20426
RoW
Ad26.ZEBOV, MVA-BN-Filo vaccine
London School of Hygiene and Tropical Medicine, Epicentre, Ministère de la Santé de la RDC, Médecins Sans Frontières, France, Coalition for Epidemic Preparedness Innovations, Janssen Vaccines & Prevention B.V., Public Health England
Ebola Virus Disease
01/22
02/22
Watson-Jones, Deborah :L
NCT04152486: Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Active, not recruiting
3
20426
RoW
Ad26.ZEBOV, MVA-BN-Filo vaccine
London School of Hygiene and Tropical Medicine, Epicentre, Ministère de la Santé de la RDC, Médecins Sans Frontières, France, Coalition for Epidemic Preparedness Innovations, Janssen Vaccines & Prevention B.V., Public Health England
Ebola Virus Disease
01/22
02/22
NCT05284097: Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Completed
2
133
RoW
Ad26.ZEBOV, MVA-BN-Filo, VAC52150
London School of Hygiene and Tropical Medicine, University of Sierra Leone, Janssen Vaccines & Prevention B.V.
Virus Diseases, Hemorrhagic Fever, Ebola, Infections, Hemorrhagic Fevers, Viral, RNA Virus Infections, Filoviridae Infections, Mononegavirales Infections, Vaccines, Immunologic Factors, Physiological Effects of Drugs, Ebola
03/23
10/24
NCT03820739: EBOVAC-Salone Extension

Completed
N/A
653
RoW
Follow-up, Blood sample collection
London School of Hygiene and Tropical Medicine, University of Sierra Leone, Janssen Vaccines & Prevention B.V., Institut National de la Santé Et de la Recherche Médicale, France, Universiteit Antwerpen
Ebola Virus Disease
06/22
07/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Muyembe-Tamfum, Jean-Jacques
NCT04152486: Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Active, not recruiting
3
20426
RoW
Ad26.ZEBOV, MVA-BN-Filo vaccine
London School of Hygiene and Tropical Medicine, Epicentre, Ministère de la Santé de la RDC, Médecins Sans Frontières, France, Coalition for Epidemic Preparedness Innovations, Janssen Vaccines & Prevention B.V., Public Health England
Ebola Virus Disease
01/22
02/22
Bausch, Daniel
NCT04152486: Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Active, not recruiting
3
20426
RoW
Ad26.ZEBOV, MVA-BN-Filo vaccine
London School of Hygiene and Tropical Medicine, Epicentre, Ministère de la Santé de la RDC, Médecins Sans Frontières, France, Coalition for Epidemic Preparedness Innovations, Janssen Vaccines & Prevention B.V., Public Health England
Ebola Virus Disease
01/22
02/22
Watson-Jones, Deborah :L
NCT04152486: Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Active, not recruiting
3
20426
RoW
Ad26.ZEBOV, MVA-BN-Filo vaccine
London School of Hygiene and Tropical Medicine, Epicentre, Ministère de la Santé de la RDC, Médecins Sans Frontières, France, Coalition for Epidemic Preparedness Innovations, Janssen Vaccines & Prevention B.V., Public Health England
Ebola Virus Disease
01/22
02/22
NCT05284097: Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Completed
2
133
RoW
Ad26.ZEBOV, MVA-BN-Filo, VAC52150
London School of Hygiene and Tropical Medicine, University of Sierra Leone, Janssen Vaccines & Prevention B.V.
Virus Diseases, Hemorrhagic Fever, Ebola, Infections, Hemorrhagic Fevers, Viral, RNA Virus Infections, Filoviridae Infections, Mononegavirales Infections, Vaccines, Immunologic Factors, Physiological Effects of Drugs, Ebola
03/23
10/24
NCT03820739: EBOVAC-Salone Extension

Completed
N/A
653
RoW
Follow-up, Blood sample collection
London School of Hygiene and Tropical Medicine, University of Sierra Leone, Janssen Vaccines & Prevention B.V., Institut National de la Santé Et de la Recherche Médicale, France, Universiteit Antwerpen
Ebola Virus Disease
06/22
07/22

Download Options